Carcinotech
Latest round
- Seed
Last raised
- Apr 2022
Total raised
- $2M
Investors
- 6
About Carcinotech
Based in Edinburgh, UK, and founded in 2018, Carcinotech Ltd. is a MedTech company manufacturing 3D-printed mini tumors developed from patient-specific cancer stem cells, primary cells, and established cell lines. The company provides 3D bioprinted models of cancer microenvironments which include CarcinoGBM™, offering a platform for in vitro high-throughput, accurate, and rapid drug discovery and screening for combinatorial and repurposed drugs; CarcinoTNBC™, which are models of triple-negative breast cancer; CarcinoER™, which are models of estrogen receptor-positive microenvironments offering a platform for in vitro high throughput drug screening; and CarcinoLC™, which are models of the lung cancer microenvironment, particularly non-small cell lung cancer. The firm's models can be used as a tool for drug testing, cancer drug discovery, and the study of cancer biology, these models are validated to ensure consistency, use advanced AI-driven manufacturing to ensure throughput and results, and are quality controlled to produce predictive assay-ready models.
Who invested in Carcinotech
6 investors across 1 round
See all investors in Carcinotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Apr 5, 2022
Amount
$2M
Investors
Questions about Carcinotech
Who invested in Carcinotech?
Carcinotech has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Carcinotech raised?
Carcinotech has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Carcinotech last raise money?
Carcinotech's most recent round on record is a Seed, in Apr 2022.
What does Carcinotech do?
Based in Edinburgh, UK, and founded in 2018, Carcinotech Ltd.
Where is Carcinotech headquartered?
Carcinotech is headquartered in Edinburgh, UK.
Which VCs invest in companies like Carcinotech?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Carcinotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Carcinotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.